ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025 16:15 ET | Source: ImageneBio, Inc. SAN DIEGO, Aug.…
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025 16:08 ET | Source: Protara Therapeutics NEW YORK, Aug.…
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025 16:05 ET | Source: Akebia Therapeutics, Inc. CAMBRIDGE, Mass.,…
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025 16:30 ET | Source: Xilio Therapeutics, Inc. WALTHAM, Mass.,…
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025 17:06 ET | Source: Taysha Gene Therapies, Inc. DALLAS,…
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025 16:55 ET | Source: Xenon Pharmaceuticals Inc. VANCOUVER, British…
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
SOUTH SAN FRANCISCO, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated…
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 18, 2025 16:00 ET | Source: Vor Biopharma CAMBRIDGE, Mass., July…
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
July 18, 2025 17:15 ET | Source: Iovance Biotherapeutics, Inc. SAN CARLOS,…
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 18, 2025 16:30 ET | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif.,…
